Hypoxic adaptation during development: Relation to pattern of neurological presentation and cognitive disability

Developmental Science

Volumn 9, Issue 4, 2006, Pages 411-427

  Kirkham, Fenella J ^a,b,c   Datta, Avijit K ^d,e  

^a UNIVERSITY HOSPITAL SOUTHAMPTON NHS FOUNDATION TRUST   (United Kingdom)

^b UNIVERSITY OF SOUTHAMPTON   (United Kingdom)

^c UNIVERSITY COLLEGE LONDON   (United Kingdom)

^d UNIVERSITY OF PORTSMOUTH   (United Kingdom)

^e NATIONAL HEALTH SERVICE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

OXYHEMOGLOBIN;

ANOXIA; ARTICLE; BRAIN; COGNITIVE DEFECT; EPILEPSY; HUMAN; METABOLISM; PATHOLOGY; SICKLE CELL ANEMIA; TIME;

ANEMIA, SICKLE CELL; ANOXIA; BRAIN; COGNITION DISORDERS; EPILEPSY; HUMANS; OXYHEMOGLOBINS; TIME FACTORS;

EID: 33744949334     PISSN: 1363755X     EISSN: 14677687     Source Type: Journal    
DOI: 10.1111/j.1467-7687.2006.00507.x     Document Type: Article

References (155)

1. Adams, R.J., McKie, V.C., Carl, E.M., Nichols, F.T., Perry, R., Brock, K., McKie, K., Figueroa, R., Litaker, M., Weiner, S., & Brambilla, D. (1997). Long-term stroke risk in children with sickle cell disease screened with transcranial Doppler. Annals of Neurology, 42, 699-704.
2. Adams, R.J., Nichols, F.T., McKie, V., McKie, K., Milner, P., & Gammal, T.E. (1988). Cerebral infarction in sickle cell anemia: mechanism based on CT and MRI. Neurology, 38, 1012-1017.
3. Allen, J.P., Imbus, C.E., Powars, D.R., & Haywood, L.J. (1976). Neurological impairment induced by hyperventilation in children with sickle cell anemia. Pediatrics, 58, 124-126.
4. Annobil, S.H., Omojola, M.F., Adzaku, F.K., Addae, S.K., & Mohammed, S. (1990). Cerebrovascular accidents (strokes) in children with sickle cell disease residing at high and low altitudes of Saudi Arabia. Annals of Tropical Paediatrics, 10, 191-198.
5. Arnow, P.M., Panwalker, A., Garvin, J.S., & Rodriguez-Erdmann, F. (1978). Aspirin, hyperventilation, and cerebellar infarction in sickle cell disease. Archives of Internal Medicine, 138, 148-149.
6. Arregui, A., Leon-Velarde, F., Cabrera, J., Paredes, S., Vizcarra, D., & Umeres, H. (1994). Migraine, polycythemia and chronic mountain sickness. Cephalalgia, 14, 339-341.
7. Ashwal, S., Bedros, A., & Thompson, J. (1994). Nifedipine increases cerebral blood flow in sickle cell disease: a case study. Journal of Child Neurology, 9, 337-338.
8. Aylett, S.E., Neville, B.G., Cross, J.H., Boyd, S., Chong, W.K., & Kirkham, F.J. (1999). Sturge-Weber syndrome: cerebral haemodynamics during seizure activity. Developmental Medicine and Child Neurology, 41, 480-485.
9. Baldeweg, T., Hogan, A.M., Saunders, D.E., Telfer, P., Gadian, D.G., Vargha-Khadem, F., & Kirkham, F.J. (2006). Detecting white matter injury in sickle cell disease using voxel-based morphometry Annals of Neurology, 59, 662-672.
10. Barcroft, J. (1920). Presidential address on anoxaemia (abridged). Lancet, 199, 485.
11. Basnyat, B., Wu, T., & Gertsch, J.H. (2004). Neurological conditions at altitude that fall outside the usual definition of altitude sickness. High Altitude Medicine and Biology, 5, 171-179.
12. Beall, C.M. (2000a). Tibetan and Andean patterns of adaptation to high-altitude hypoxia. Human Biology, 72, 201-228.
13. Beall, C.M. (2000b). Oxygen saturation increases during childhood and decreases during adulthood among high altitude native Tibetians residing at 3800-4200 m. High Altitude Medicine and Biology, 1, 25-32.
14. Beall, C.M. (2003). High-altitude adaptations. Lancet, 362, Suppl, 14-15.
15. Beall, C.M., Decker, M.J., Brittenham, G.M., Kushner, I., Gebremedhin, A., & Strohl, K.P. (2002). An Ethiopian pattern of human adaptation to high-altitude hypoxia. Proceedings of the National Academy of Science, USA, 99, 17215-17218.
16. Beall, C.M., Laskowski, D., Strohl, K.P., Soria, R., Villena, M., Vargas, E., Alarcon, A.M., Gonzales, C., & Erzurum, S.C. (2001). Pulmonary nitric oxide in mountain dwellers. Nature, 414, 411-412.
17. Beran, R.G., Holland, G.J., & Yan, K.Y. (1997). The use of CPAP in patients with refractory epilepsy. Seizure, 6, 323-325.
18. Bertuglia, S., & Giusti, A. (2005). Role of nitric oxide in capillary perfusion and oxygen delivery regulation during systemic hypoxia. American Journal of Physiology and Heart Circulation Physiology, 288, H525-H531.
19. Brett, E.M. (1966). Minor epileptic status. Journal of Neurological Science, 3, 52-75.
20. Brodersen, P., Paulson, O.B., Bolwig, T.G., Rogon, Z.E., Rafaelsen, O.J., & Lassen, N.A. (1973). Cerebral hyperemia in electrically induced epileptic seizures. Archives of Neurology, 28, 334-338.
21. Bussolati, B., Ahmed, A., Pemberton, H., Landis, R.C., Di Carlo, F., Haskard, D.O., & Mason, J.C. (2004). Bifunctional role for VEGF-induced heme oxygenase-1 in vivo: induction of angiogenesis and inhibition of leukocytic infiltration. Blood, 103, 761-766.
22. Calbet, J.A. (2003). Chronic hypoxia increases blood pressure and noradrenaline spillover in healthy humans. Journal of Physiology, 551, 379-386.
23. Chang, Y.S., Mu, D., Wendland, M., Sheldon, R.A., Vexler, Z.S., Maquillen, P.S., & Ferriero, D.M. (2005). Erythropoietin improves functional and histological outcome in neonatal stroke. Pediatric Research, 58, 106-111.
24. Cohen, S.R., Lefaivre, J.F., Burstein, F.D., Simms, C., Kattos, A.V., Scott, PH., Montgomery, G.L., & Graham, L. (1997). Surgical treatment of obstructive sleep apnea in neurologically compromised patients. Plastic and Reconstructive Surgery, 99, 638-646.
25. Crawford, J.H., Isbell, T.S., Huang, Z., Shiva, S., Chacko, B.K., Schechter, A.N., Darley-Usmar, V.M., Kerby, J.D., Lang, J.D. Jr., Kraus, D., Ho, C., Gladwin, M.T., & Patel, R.P. (2005). Hypoxia, red blood cells and nitrite regulate NO-dependent hypoxic vasodilation. Blood, 107, 566-574.
26. Crisostomo, I., Zayyad, A., Carley, D.W., Abubaker, J., Onal, E., Stepanski, E.J., Lopata, M., & Basner, R.C. (1998). Chemo- and baroresponses differ in African-Americans and Caucasians in sleep. Journal of Applied Physiology, 85, 1413-1420.
27. Croll, S.D., Goodman, J.H., & Scharfman, H.E. (2004). Vascular endothelial growth factor (VEGF) in seizures: a double-edged sword. Advances in Experimental and Medical Biology, 548, 57-68.
28. Cunnington, A.J., Kendrick, S.F., Wamola, B., Lowe, B., & Newton, C.R. (2004). Carboxyhemoglobin levels in Kenyan children with Plasmodium falciparum malaria. American Journal of Tropical Medicine and Hygiene, 71, 43-47.
29. Curran-Everett, D. (2003). Oxygen-hemoglobin affinity at sea level may predict acute illness at altitude: theory and simulation. Medical Hypotheses, 60, 767-774.
30. Datta, A., & Tipton, M. (2006). Respiratory responses to cold water immersion: neural pathways, interactions and clinical consequences. Journal of Applied Physiology (in press).
31. Davies, S.C., Stebbens, V.A., Samuels, M.P., & Southall, D.P. (1989). Upper airways obstruction and cerebrovascular accident in children with sickle cell anaemia. Lancet, 2, 283-284.
32. Del Bo, R., Scarlato, M., Ghezzi, S., Martinelli Boneschi, F., Fenoglio, C., Galbiati, S., Virgilio, R., Galimberti, D., Galimberti, G., Crimi, M., Ferrarese, C., Scarpini, E., Bresolin, N., & Comi, G.P. (2005). Vascular endothelial growth factor gene variability is associated with increased risk for AD. Annals of Neurology, 57, 373-380.
33. Di Giulio, C., Bianchi, G., Cacchio, M., Artese, L., Rapino, C., Macri, M.A., & Di Ilio, C. (2005). Oxygen and life span: chronic hypoxia as a model for studying HIF-1 alpha, VEGF and NOS during aging. Respiratory and Physiological Neurobiology, 147, 31-38.
34. Dill, D.B. (Ed.) (1964). Handbook of physiology, Section 4. Washington, DC: American Physiological Society.
35. Dowling, M.M. (2005). Clinical experience in 24 months of a dedicated sickle cell neurology clinic. Proceedings of the 28th Annual Meeting of the National Sickle Cell Disease Program, 111.
36. Drury, I. (2002). EEG in benign and malignant epileptic syndromes of childhood. Epilepsia, 43 (Suppl 3), 17-26.
37. Dulac, O.J., & Chiron, C. (1996). Malignant epileptic encephalopathies in children. Baillieres Clinical Neurology, 5, 765-781.
38. Durak, A.C., Coskun, A., Yikilmaz, A., Erdogan, F., Mavili, E., & Guven, M. (2005). Magnetic resonance imaging findings in chronic carbon monoxide intoxication. Acta Radiologica, 46, 322-327.
39. Fabry, M.E., Etzion, Z., Bookchin, R.M., Suzuka, S.M., & Nagel, R.L. (2004). Arginine supplementation of sickle transgenic mice leads to a rapid decrease in MCHC and percent dense cells and a slow increase when supplementation is discontinued. Blood, 104, 973.
40. Fasipe, F.R., Ubawike, A.E., Eva, R., & Fabry, M.E. (2004). Arginine supplementation improves rotorod performance in sickle transgenic mice. Hematology, 9, 301-305.
41. 2 in high-altitude natives and patients with chronic mountain sickness. Journal of Applied Physiology, 94, 1279-1287; discussion 1253-1254.
42. Ferrie, C.D., Maisey, M., Cox, T., Polkey, C., Barrington, S.F., Panayiotopoulos, C.P., & Robinson, R.O. (1996). Focal abnormalities detected by 18FDG PET in epileptic encephalopathies. Archives of Diseases in Childhood, 75, 102-107.
43. Finsterer, J., Sommer, O., Stiskal, M., Stollberger, C., & Baumgartner, H. (2005). Closure of a patent foramen ovale: effective therapy of migraine and occipital stroke. International Journal of Neuroscience, 115, 119-127.
44. Fowler, N.O., Smith, O., & Greenfield, J.C. (1957). Arterial blood oxygenation in sickle cell anemia. American Journal of Medical Science, 234, 449-458.
45. French, J.A., Kenny, D., Scott, J.P., Hoffmann, R.G., Wood, J.D., Hudetz, A.G., & Hillery, C.A. (1997). Mechanisms of stroke in sickle cell disease: sickle erythrocytes decrease cerebral blood flow in rats after nitric oxide synthase inhibition. Blood, 89, 4591-4599.
46. Fullerton, H.J., Adams, R.J., Zhao, S., & Johnston, S.C. (2004). Declining stroke rates in Californian children with sickle cell disease. Blood, 104, 336-339.
47. Gladwin, M.T., Crawford, J.H., & Patel, R.P. (2004). The biochemistry of nitric oxide, nitrite, and hemoglobin: role in blood flow regulation. Free Radical Biological Medicine, 36, 707-717.
48. Gladwin, M.T., & Kato, G.J. (2005). Cardiopulmonary complications of sickle cell disease: role of nitric oxide and haemolytic anemia. Hematology (Am Soc Hematol Educ Program), 51-57.
49. Gozal, E., & Gozal, D. (2001). Respiratory plasticity following intermittent hypoxia: developmental interactions. Journal of Applied Physiology, 90, 1995-1999.
50. Grabowski, M., & Johansson, B.B. (1985). Nifedipine and nimodipine: effect on blood pressure and regional cerebral blood flow in conscious normotensive and hypertensive rats. Journal of Cardiovascular Pharmacology, 7, 1127-1133.
51. Graham, D.I., Adams, J.H., & Doyle, D. (1978). Ischaemic brain damage in fatal non-missile head injuries. Journal of Neurological Science, 39, 213-234.
52. Green, R.L., Huntsman, R.G., & Serjeant, G.R. (1971). The sickle-cell and altitude. British Medical Journal, 4, 593-595.
53. Gurkan, E., Tanriverdi, K., & Baslamisli, F. (2004). Clinical relevance of vascular endothelial growth factor levels in sickle cell disease. Annals of Hematology, 84, 71-75.
54. Hackett, P.H., Yarnell, P.R., Hill, R., Reynard, K., Heit, J., & McCormick, J. (1998). High-altitude cerebral edema evaluated with magnetic resonance imaging: clinical correlation and pathophysiology. Journal of the American Medical Association, 280, 1920-1925.
55. Hagen, T., Taylor, C.T., Lam, F., & Moncada, S. (2003). Redistribution of intracellular oxygen in hypoxia by nitric oxide: effect on HIF1alpha. Science, 302, 1975-1978.
56. Helton, R., Cui, J., Scheel, J.R., Ellison, J.A., Ames, C., Gibson, C., Blouw, B., Ouyang, L., Dragatsis, I., Zeitlin, S., Johnson, R.S., Lipton, S.A., & Barlow, C. (2005). Brainspecific knock-out of hypoxia-inducible factor-1alpha reduces rather than increases hypoxic-ischemic damage. Journal of Neuroscience, 25, 4099-4107.
57. Henderson, J.N., Noetzel, M.J., McKinstry, R.C., White, D.A., Armstrong, M., & DeBaun, M.R. (2003). Reversible posterior leukoencephalopathy syndrome and silent cerebral infarcts are associated with severe acute chest syndrome in children with sickle cell disease. Blood, 101, 415-419.
58. Henry, M., Driscoll, M.C., Miller, M., Chang, T., & Minniti, C.P. (2004). Pseudotumor cerebri in children with sickle cell disease: a case series. Pediatrics, 113, e265-e269.
59. Herold, S., Brozovic, M., Gibbs, J., Lammertsma, A.A., Leenders, K.L., Carr, D., Fleming, J.S., & Jones, T. (1986). Measurement of regional cerebral blood flow, blood volume and oxygen metabolism in patients with sickle cell disease using positron emission tomography. Stroke, 17, 692-698.
60. Hill, C.M., & Hogan, A.M. (joint first authors), Onugha, N.N., Harrison, D., Cooper, S., McGrigor, V.J., Datta, A., & Kirkham, F.J. (2006). Increased cerebral blood flow velocity in children with primary snoring: associations with cognitive function. Pedriatics (in press).
61. Hogan, A.M., Kirkham, F.J., & Isaacs, E. (2000). Intelligence after stroke in childhood: a review of the literature and suggestions for future research. Journal of Child Neurology, 15, 325-332.
62. Hogan, A.M., Kirkham, F.J., Isaacs, E.B., Wade, A.M., & Vargha-Khadem, F. (2005). Intellectual decline in children with moyamoya and sickle cell anaemia. Developmental Medicine & Child Neurology, 47, 824-829.
63. Hogan, A.M., Kirkham, F.J., Prengler, M., Telfer, P., Lane, R., Vargha-Khadem, F., & de Haan, M. (2005). Physiological correlates of neurodevelopmental delay in infants with sickle cell anaemia: an exploratory study. British Journal of Haematology, 132, 99-107.
64. Huttenlocher, P.R., Moohr, J.W., Johns, L., & Brown F.D. (1984). Cerebral blood flow in sickle cell cerebrovascular disease. Pediatrics, 73, 615-621.
65. Inwald, D.P., Kirkham, F.J., Peters, M.J., Lane, R., Wade, A., Evans, J.P., & Klein, N.J. (2000). Platelet and leukocyte activation in childhood sickle cell disease: association with nocturnal hypoxaemia. British Journal of Haema to logy, 111, 474-481.
66. Jaillard, A.S., Mazetti, P., & Kala, E. (1997). Prevalence of migraine and headache in a high-altitude town of Peru: a population-based study. Headache, 37, 95-101.
67. Jensen, F.E., Holmes, G.L., Lombroso, C.T., Blume, H.K., & Firkusny, I.R. (1992). Age-dependent changes in long-term seizure susceptibility and behavior after hypoxia in rats. Epilepsia, 33, 971-980.
68. Jeong, J.H., Kwon, J.C., Chin, J., Yoon, S.J., & Na, D.L. (2002). Globus pallidus lesions associated with high mountain climbing. Journal of Korean Medical Science, 17, 861-863.
69. Jison, M.L., Munson, P.J., Barb, J.J., Suffredini, A.F., Talwar, S., Logun, C., Raghavachari, N., Beigel, J.H., Shelhamer, J.H., Danner, R.L., & Gladwin, M.T. (2004). Blood mononuclear cell gene expression profiles characterize the oxidant, hemolytic, and inflammatory stress of sickle cell disease. Blood, 104, 270-280.
70. Kaul, D.K., & Hebbel, R.P. (2000). Hypoxia/reoxygenation causes inllammatory response in transgenic sickle mice but not in normal mice. Journal of Clinical Investigation, 106, 411-420.
71. Kedar, A., Drane, W.E., Shaeffer, D., Nicole, M., & Adams, C. (2006). Measurement of cerebrovascular flow reserve in pediatric patients with sickle cell disease. Pediatric Blood Cancer, 46 (2), 234-238.
72. Kennan, R.P., Suzuka, S.M., Nagel, R.L., & Fabry, M.E. (2002). Detection of increased cerebral response to hyperoxia in sickle cell patients by transcranial near infrared spectroscopy. Blood, 100, 2611.
73. Kennan, R.P., Suzuka, S.M., Nagel, R.L., & Fabry, M.E. (2003). Arginine supplementation ameliorates elevated deoxyhemoglobin and poor perfusion in sickle knockout mice as detected by MRI. Blood, 102, 128.
74. Kennan, R.P., Suzuka, S.M., Nagel, R.L., & Fabry, M.E. (2004). Decreased cerebral perfusion correlates with increased BOLD hyperoxia response in transgenic mouse models of sickle cell disease. Magnetic Resonance Medicine, 51, 525-532.
75. Kinney, T.R., Sleeper, L.A., Wang, W.C., Zimmerman, R.A., Pegelow, C.H., Ohene-Frempong, K., Wethers, D.L., Bello, J.A., Vichinsky, E.P., Moser, F.G., Gallagher, D.M., DeBaun, M.R., Platt, O.S., & Miller, S.T. (1999). Silent cerebral infarcts in sickle cell anemia: a risk factor analysis. The Cooperative Study of Sickle Cell Disease. Pediatrics, 103, 640-645.
76. Kirkham, F.J., Calamante, F., Bynevelt, M., Gadian, D.G., Cox, T.C., Evans, J.P.M., & Connelly, A. (2001b). Perfusion MR abnormalities in patients with sickle cell disease: relation to symptoms, infarction and cerebrovascular disease. Annals of Neurology, 49, 477-485.
77. Kirkham, F.J., & DeBaun, M.R. (2004). Stroke in children with sickle cell disease. Current Treatment Options in Neurology, 6, 357-375.
78. Kirkham, F.J., Hewes, D.K., Prengler, M., Wade, A., Lane, R., & Evans, J.P. (2001 a). Nocturnal hypoxaemia and centralnervous-system events in sickle-cell disease. Lancet, 357, 1656-1659.
79. Kobayashi, T., Koyama, S., Kubo, K., Fukushima, M., & Kusama, S. (1987). Clinical features of patients with high-altitude pulmonary edema in Japan. Chest, 92, 814-821.
80. Koh, S., Ward, S.L., Lin, M., & Chen, L.S. (2000). Sleep apnea treatment improves seizure control in children with neurodevelopmental disorders. Pediatric Neurology, 22, 36-39.
81. LaManna, J.C., Chavez, J.C., & Pichiule, P. (2004). Structural and functional adaptation to hypoxia in the rat brain. Journal of Experimental Biology, 207, 3163-3169.
82. Lee, K.H., McKie, V.C., Sekul, E.A., Adams, R.J., & Nichols, FT. (2002). Unusual encephalopathy after acute chest syndrome in sickle cell disease: acute necrotizing encephalitis. Journal of Pediatric Hematology and Oncology, 24, 585-588.
83. Lipton, A.J., Johnson, M.A., Macdonald, T., Lieberman, M.W., Gozal, D., & Gaston, B. (2001). S-nitrosothiols signal the ventilatory response to hypoxia. Nature, 413, 171-174.
84. Liu, J.E., Gzesh, D.J., & Ballas, S.K. (1994). The spectrum of epilepsy in sickle cell anemia. Journal of Neurological Science, 123, 6-10.
85. Longo, L.D., & Pearce, W.J. (2005). Fetal cerebrovascular acclimatization responses to high-altitude, long-term hypoxia: a model for prenatal programming of adult disease? American Journal of Physiology, 288, R16-R24.
86. Macarlupu, J.L., Buvry, A., Morel, O.E., Leon-Velarde, F., Richalet, J.P., & Favret, F. (2006). Characterisation of the ventilatory response to hypoxia in a model of transgenic anemic mice. Respiratory and Physiological Neurobiology, 150 (1), 19-26.
87. McFarland, R.A., & Evans, J.N. (1939). Alterations in dark adaptation under reduced oxygen tensions. Journal of Physiology, 127, 37.
88. Maddern, B.R., Reed, H.T., Ohene-Frempong, K., & Beckerman, R.C. (1989). Obstructive sleep apnea syndrome in sickle cell disease. Annals of Otolaryngology, Rhinology and Laryngology, 98, 174-178.
89. Malow, B.A., Levy, K., Maturen, K., & Bowes, R. (2000). Obstructive sleep apnea is common in medically refractory epilepsy patients. Neurology, 55, 1002-1007.
90. Maria, B.L., Neufeld, J.A., Rosainz, L.C., Drane, W.E., Quisling, R.G., Ben-David, K., & Hamed, L.M. (1998). Central nervous system structure and function in Sturge-Weber syndrome: evidence of neurologic and radiologie progression. Journal of Child Neurology, 13, 606-618.
91. Mejia, O.M., Prchal, J.T., Leon-Velarde, F., Hurtado, A., & Stockton, D.W. (2005). Genetic association analysis of chronic mountain sickness in an Andean high-altitude population. Haematologica, 90, 13-19.
92. Minoguchi, K., Yokoe, T., Tazaki, T., Minoguchi, H., Tanaka, A., Oda, N., Okada, S., Ohta, S., Naito, H., & Adachi, M. (2005). Increased carotid intima-media thickness and serum inflammatory markers in obstructive sleep apnea. American Journal of Respiratory and Critical Care Medicine, 172, 625-630.
93. Miyamoto, O., & Auer, R.N. (2000). Hypoxia, hyperoxia, ischemia, and brain necrosis. Neurology, 54, 362-371.
94. Morris, C.R., Kato, G.J., Poljakovic, M., Wang, X., Blackwelder, W.C., Sachdev, V., Hazen, S.L., Vichinsky, E.P., Morris, S.M. Jr., & Gladwin, M.T. (2005). Dysregulated arginine metabolism, hemolysis-associated pulmonary hypertension, and mortality in sickle cell disease. Journal of the American Medical Association, 294, 81-90.
95. Murase, M., & Ishida, A. (2005). Early hypocarbia of preterm infants: its relationship to periventricular leukomalacia and cerebral palsy, and its perinatal risk factors. Acta Paediatrica, 94, 85-91.
96. Nahavandi, M., Tavakkoli, F., Hasan, S.P., Wyche, M.Q., & Castro, O. (2004). Cerebral oximetry in patients with sickle cell disease. European Journal of Clinical Investigation, 34, 143-148.
97. Ng, I., Tan, W.L., Ng, P.Y., & Lim, J. (2005). Hypoxia inducible factor-lalpha and expression of vascular endothelial growth factor and its receptors in cerebral arteriovenous malformations. Journal of Clinical Neuroscience, 12, 794-799.
98. Nordness, M.E., Lynn, J., Zacharisen, M.C., Scott, P.J., & Kelly, K.J. (2005). Asthma is a risk factor for acute chest syndrome and cerebral vascular accidents in children with sickle cell disease. Clinical and Molecular Allergy, 3, 2.
99. Numaguchi, Y., Haller, J.S., Humbert, J.R., Robinson, A.E., Lindstrom, W.W., Gruenauer, L.M., & Carey, J.E. (1990). Cerebral blood flow mapping using stable xenon-enhanced CT in sickle cell cerebrovascular disease. Neuroradiology, 32, 289-295.
100. Onodera, H., Okabe, S., Kikuchi, Y., Tsuda, T., & Itoyama, Y. (2000). Impaired chemosensitivity and perception of dyspnoea in Parkinson's disease. Lancet, 356, 739-740.
101. Palermo, T.M., Platt-Houston, C., Kiska, R.E., & Berman, B. (2005). Headache symptoms in pediatric sickle cell patients. Journal of Pediatric Hematology and Oncology, 27, 420-424.
102. Pascual-Castroviejo, I., Lopez Martin, V., Martinez Bermejo, A., & Perez. Higueras, A. (1994). Is cerebral arteritis the cause of the Landau-Kleffner syndrome? Four cases in childhood with angiographie study. Canadian Journal of Neurological Science, 19, 46-52.
103. Pavlakis, S.G., Bello, J., Prohovnik, I., Sutton, M., Ince, C., Mohr, J.P., Piomelli, S., Hilal, S., & De Vivo, B.C. (1988). Brain infarction in sickle cell anemia: magnetic resonance imaging correlates. Annals of Neurology, 23, 125-130.
104. Pawloski, J.R., Hess, D.T., & Stamler, J.S. (2005). Impaired vasodilation by red blood cells in sickle cell disease. Proceedings of the National Academy of Science, USA, 102, 2531-2536.
105. Perelman, N., Selvaraj, S.K., Batra, S., Luck, L.R., Erdreich-Epstein, A., Coates, T.D., Kalra, V.K., & Malik, P. (2003). Placenta growth factor activates monocytes and correlates with sickle cell disease severity. Blood, 102, 1506-1514.
106. Peyssonnaux, C., Datta, V., Cramer, T., Doedens, A., Theodorakis, E.A., Gallo, R.L., Hurtado-Ziola, N., Nizet, V., & Johnson, R.S. (2005). HIF-1alpha expression regulates the bactericidal capacity of phagocytes. Journal of Clinical Investigation, 115, 1806-1815.
107. Pluta, R.M., Dejam, A., Grimes, G., Gladwin, M.T., & Oldfield, E.H. (2005). Nitrite infusions to prevent delayed cerebral vasospasm in a primate model of subarachnoid hemorrhage. Journal of the American Medical Association, 293, 1477-1484.
108. Powars, D.R., Weiss, J.N., Chan, L.S., & Schroeder, W.A. (1984). Is there a threshold level of fetal hemoglobin that ameliorates morbidity in sickle cell anemia? Blood, 63, 921-926.
109. Powars, D.R., Conti, P.S., Wong, W.Y., Groncy, P., Hyman, C., Smith, E., Ewing, N., Keenan, R.N., Zee, C.S., Harold, Y., Hiti, A.L., Teng, E.L., & Chan, L.S. (1999). Cerebral vasculopathy in sickle cell anemia: diagnostic contribution of positron emission tomography. Blood, 93, 71-79.
110. Prengler, M., Pavlakis, S.G., Boyd, S., Connelly, A., Calamante, F., Chong, W.K., Saunders, D., Cox, T., Bynevelt, M., Lane, R., Laverty, A., & Kirkham, F.J. (2005). Sickle cell disease: ischemia and seizures. Annals of Neurology, 58, 290-302.
111. Prohovnik, I., Pavlakis, S.G., Piomelli, S., Bello, I., Mohr, J.P., Hilal, S., & De Vivo, D.C. (1989). Cerebral hyperemia,stroke, and transfusion in sickle cell disease. Neurology, 39, 344-348.
112. Protass, L.M. (1973). Possible precipitation of cerebral thrombosis in sickle-cell anemia by hyperventilation. Annals of Internal Medicine, 79, 451.
113. Rackoff, W.R., Kunkel, N., Silber, J.H., Asakura, T., & Ohene-Frempong, K. (1993). Pulse oximetry and factors associated with hemoglobin oxygen desaturation in children with sickle cell disease. Blood, 81, 3422-3427.
114. Raj, A., Bertolone, S.J., Mangold, S., & Edmonds, H.L. Jr. (2004). Assessment of cerebral tissue oxygenation in patients with sickle cell disease: effect of transfusion therapy. Journal of Pediatric Hematologly and Oncology, 26, 279-283.
115. Raj, A.B., O'Brien, L.M., Edmonds, H.L., Bertolone, S.J., & Gozal, D. (2005). Use of transcranial near infrared spectroscopy to identify sickle cell patients at risk for nocturnal cerebral hypoxia. Proceedings of the 28th Annual Meeting of the National Sickle Cell Disease Program, 111.
116. Rapino, C., Bianchi, G., Di Giulio, C., Centurione, L., Cacchio, M., Antonucci, A., & Cataldi, A. (2005). HIF-1 alpha cytoplasmic accumulation is associated with cell death in old rat cerebral cortex exposed to intermittent hypoxia. Aging Cell, 4, 177-185.
117. Reiter, C.D., Wang, X., Tanus-Santos, J.E., Hogg, N., Cannon, R.O. 3rd, Schechter, A.N., & Gladwin, M.T. (2002). Cellfree hemoglobin limits nitric oxide bioavailability in sicklecell disease. Nature Medicine, 8, 1383-1389.
118. Rice, L., & Alfrey, C.P. (2005). The negative regulation of red cell mass by neocytolysis: physiologic and pathophysiologic manifestations. Cellular Physiology and Biochemistry, 15, 245-250.
119. Rivard, A., Berthou-Soulie, L., & Principe, N. (2000). Age dependent defect in vascular endothelial growth factor expression is associated with reduced hypoxia-inducible factor 1 activity. Journal of Biological Chemistry, 275, 29643-29647.
120. Romero, J.R., Suzuka, S.M., Nagel, R.L., & Fabry, M.E. (2002). Arginine supplementation of sickle transgenic mice reduces red cell density and Gardos channel activity. Blood, 99, 1103-1108.
121. Rostrup, E., Larsson, H.B., Born, A.P., Knudsen, G.M., & Paulson, O.B. (2005). Changes in BOLD and ADC weighted imaging in acute hypoxia during sea-level and altitude adapted states. Neuroimage, 28, 947-955.
122. Saito, S., & Tanaka, S.K. (2003). A case of cerebral sinus thrombosis developed during a high-altitude expedition to Gasherbrum I. Wilderness Environmental Medicine, 14, 226-230.
123. Samaja, M., Crespi, T., Guazzi, M., & Vandegriff, K.D. (2003). Oxygen transport in blood at high altitude: role of the hemoglobin-oxygen affinity and impact of the phenomena related to hemoglobin allosterism and red cell function. European Journal of Applied Physiology, 90, 351-359.
124. Samuels, M.P., Stebbens, V.A., Davies, S.C., Picton-Jones, E., & Southall, D.P. (1992). Sleep related upper airway obstruction and hypoxaemia in sickle cell disease. Archives of Disease in Childhood, 67, 925-929.
125. Schatz, J., & Buzan, R. (2006). Decreased corpus callosum size in sickle cell disease: relationship with cerebral infarcts and cognitive functioning. Journal of the International Neuropsychological Society, 12, 24-33.
126. Schoch, H.J., Fischer, S., & Marti, H.H. (2002). Hypoxiainduced vascular endothelial growth factor expression causes vascular leakage in the brain. Brain, 125, 2549-2557.
127. Sébire, G., Tabarki, B., Saunders, D.E., Leroy, I., Liesner, R., Saint-Martin, C., Husson, B., Williams, A.N., & Kirkham, F.J. (2005). Venous sinus thrombosis in children. Brain, 128, 477-489.
128. Semenza, G.L. (2001). Hypoxia-inducible factor 1: control of oxygen homeostasis in health and disease. Pediatric Research, 49, 614-617.
129. Setty, B.Y., Stuart, M.J., Dampier, C., Brodecki, D., & Allen, J.L. (2003). Hypoxemia in sickle cell disease: biomarker modulation and relevance to disease pathophysiology. Lancet, 362, 1450-1455.
130. Shanoudy, H., Soliman, A., Raggi, P., Liu, J.W., Russell, D.C., & Jarmukli, N.F. (1998). Prevalence of patent foramen ovale and its contribution to hypoxemia in patients with obstructive sleep apnea. Chest, 113, 91-96.
131. Shein, N.A., Horowitz, M., Alexandrovich, A.G., Tsenter, J., & Shohami, E. (2005). Heat acclimation increases hypoxiainducible factor 1 alpha and erythropoietin receptor expression: implication for neuroprotection after closed head injury in mice. Journal of Cerebral Blood Flow and Metabolism, 25, 1456-1465.
132. Sherwood, J.B., Goldwasser, E., Chilcote, R., Carmichael, L.D., & Nagel, R.L. (1986). Sickle cell anemia patients have low erythropoietin levels for their degree of anemia. Blood, 67, 46-49.
133. Shnaider, H., Shiran, A., & Lorber, A. (2004). Right ventricular diastolic dysfunction and patent foramen ovale causing profound cyanosis. Heart, 90, e31.
134. Singel, D.J., & Stamler, J.S. (2005). Chemical physiology of blood flow regulation by red blood cells: the role of nitric oxide and S-nitrosohemoglobin. Annual Review of Physiology, 67, 99-145.
135. Soliman, A., Shanoudy, J.L., Liu, J., Russell, D.C., & Jarmukli, N.F. (1999). Increased prevalence of patent foramen ovale in patients with severe chronic obstructive pulmonary disease. Journal of the American Society of Echocardiographers, 12, 99-105.
136. Solovey, A., Gui, L., Ramakrishnan, S., Steinberg, M.H., & Hebbel, R.P. (1999). Sickle cell anemia as a possible state of enhanced anti-apoptotic tone: survival effect of vascular endothelial growth factor on circulating and unanchored endothelial cells. Blood, 93, 3824-3830.
137. Stamler, J.S., Jia, L., Eu, J.P., McMahon, T.J., Demchenko, I.T., Bonaventura, J., Gernert, K., & Piantadosi, C.A. (1997). Blood flow regulation by S-nitrosohemoglobin in the physiological oxygen gradient. Science, 276, 2034-2037.
138. Steen, R.G., Langston, J.W., Reddick, W.E., Ogg, R., Chen, G., & Wang, W.C. (1996). Quantitative MR imaging of children with sickle cell disease: striking T1 elevation in the thalamus. Journal of Magnetic Resonance Imaging, 6, 226-234.
139. Steen, R.G., Reddick, W.E., Glass, J.O., & Wang, W.C. (1998). Evidence of cranial artery ectasia in sickle cell disease patients with ectasia of the basilar artery. Journal of Stroke and Cerebrovascular Disease, 7, 330-338.
140. Steen, R.G., Xiong, X., Mulhern, R.K., Langsten, J.W., & Wang, W.C. (1999). Subtle brain abnormalities in children with sickle cell disease: relationship to blood hematocrit. Annals of Neurology, 45, 279-286.
141. Stenzel-Poore, M.P., Stevens, S.L., Xiong, Z., Lessov, N.S., Harrington, C.A., Mori, M., Meiler, R., Rosenzweig, H.L., Tobar, E., Shaw, T.E., Chu, X., & Simon, R.P. (2003). Effect of ischaemic preconditioning on genomic response to cerebral ischaemia: similarity to neuroprotective strategies in hibernation and hypoxia-tolerant states. Lancet, 362, 1028-1037.
142. Stockman, J.A., Nigro, M.A., Mishkin, M.M., & Oski, P.A. (1972). Occlusion of large cerebral vessels in sickle-cell anemia. New England Journal of Medicine, 287, 846-849.
143. Sylvester, K.P., Patey, R.A., Rafferty, G.F., Rees, D., Thein, S.L., & Greenough, A. (2005). Exhaled carbon monoxide levels in children with sickle cell disease. European Journal of Pediatrics, 164, 162-165.
144. Terblanche, J.S., Tolley, K.A., Fahlman, A., Myburgh, K.H., & Jackson, S. (2005). The acute hypoxic ventilatory response: testing the adaptive significance in human populations. Comparative Biochemistry and Physiology A - Molecular and Integmtive Physiology, 140, 349-362.
145. Tissot van Patot, M.C., Leadbetter, G., Keyes, L.E., Bendrick-Peart, J., Beckey, V.E., Christians, U., & Hackett, P. (2005). Greater free plasma VEGF and lower soluble VEGF receptor1 in acute mountain sickness. Journal of Applied Physiology, 98, 1626-1629.
146. Urschitz, M.S., Wolff, J., Von Einem, V., Urschitz-Duprat, P.M., Schlaud, M., & Poets, C.F. (2003). Reference values for nocturnal home pulse oximetry during sleep in primary school children. Chest, 123, 96-101.
147. Usui, C., Inoue, Y., Kimura, M., Kirino, E., Nagaoka, S., Abe, M., Nagata, T., & Arai, H. (2004). Irreversible subcortical dementia following high altitude illness. High Altitude Medicine and Biology, 5, 77-81.
148. van Dijk, E.J., Vermeer, S.E., de Groot, J.C., van de Minkelis, J., Prins, N.D., Oudkerk, M., Hofman, A., Koudstaal, P.J., & Breteler, M.M. (2004). Arterial oxygen saturation, COPD, and cerebral small vessel disease. Journal of Neurology, Neurosurgery and Psychiatry, 75, 733-736.
149. van Tuyl, M., Liu, I., Wang, I., Kuliszewski, M., Tibboel, D., & Post, M. (2005). Role of oxygen and vascular development in epithelial branching morphogenesis of the developing mouse lung. American Journal of Physiology and Lung Cell Molecular Physiology, 288, L167-L178.
150. Venketasubramanian, N., Prohovnik, I., Hurlet, A., Mohr, J.P., & Piomelli, S. (1994). Middle cerebral artery velocity changes during transfusion in sickle cell anemia. Stroke, 25, 2153-2158.
151. Vichinsky, E.P., Neumayr, L.D., Earles, A.N., Williams, R., Lennette, E.T., Dean, D., Nickerson, B., Orringer, E., McKie, V., Bellevue, R., Daeschner, C., & Manci, E.A. (2000). Causes and outcomes of the acute chest syndrome in sickle cell disease. National Acute Chest Syndrome Study Group. New England Journal of Medicine, 342, 1855-1865.
152. Wang, W.C., Langsten, J.W., Steen, R.G., Wynn, L.W., Mulhern, R.K., Wilimas, J.A., Kim, P.M., & Figueroa, R.E. (1998). Abnormalities of the central nervous system in very young children with sickle cell anemia. Journal of Pediatrics, 132, 994-998.
153. Werdehoff, S.G., Moore, R.B., Hoff, C.J., Fillingim, E., & Hackman, A.M. (1998). Elevated plasma endothelin-1 levels in sickle cell anemia: relationships to oxygen saturation and left ventricular hypertrophy. American Journal of Hematology, 58, 195-199.
154. Williams, J.M., & Pearce, W.J. (2005). Age-dependent modulation of endothelium-dependent vasodilatation by chronic hypoxia in ovine cranial arteries. Journal of Applied Physiology, 100, 225-232.
155. Wolin, M.J., & Brannon, W.L. (1995). Disk edema in an over-weight woman. Survey of Ophthalmology, 39, 307-314.